Rising use of weight-loss and diabetes medicine boosts earnings for Cigna
The sharp uptick in use of medicine like Novo Nordisk A/S’s Ozempic and Wegovy, and Eli Lilly & Co.’s Mounjaro is elevating alarms about prices to well being insurers, employers and authorities packages that pay for them. Evernorth Chief Government…